Current Edition

BARDA and Hememics Collaborate to Develop Rapid Diagnostic to Identify SARS-CoV-2

by Global Biodefense Staff April 17, 2020, 6:37 pm
BARDA and Sanofi Prepare for Studies of COVID-19 Vaccine

by Global Biodefense Staff April 17, 2020, 6:00 pm
FDA Accepts for Priority Review for REGN-EB3 to Treat Ebola

by Global Biodefense Staff April 16, 2020, 4:03 pm
Abbott Launches Laboratory-Based Antibody Blood Test with Manufacturing Scaling Targets

by Global Biodefense Staff April 15, 2020, 3:58 pm
BARDA Facilitates Development of Immunotherapies for COVID-19 Patients

by Global Biodefense Staff April 14, 2020, 5:09 pm
BARDA and Vela Diagnostics partner to develop rapid diagnostic test for the COVID-19

by Global Biodefense Staff April 14, 2020, 3:50 pm
Ridgeback Receives UK Clearance to Begin Human Testing of Antiviral for COVID-19

by Global Biodefense Staff April 14, 2020, 3:00 pm
BARDA Supports DiaSorin to Develop a Fully Automated Serology Test to Detect COVID-19 Infections

by Global Biodefense Staff April 13, 2020, 5:00 pm
Lilly Begins Clinical Testing of Therapies for COVID-19

by Global Biodefense Staff April 11, 2020, 3:18 pm
Rapid Lab-Free PCR COVID-19 Test in Development by DnaNudge and Imperial College

by Global Biodefense Staff April 10, 2020, 8:02 pm
DuPont to Produce up to 4.5 Million TYVEK Protective Suits for U.S. Healthcare Workers

by Global Biodefense Staff April 9, 2020, 9:12 am
HHS Announces Ventilator Contract with Philips under Defense Production Act

by Global Biodefense Staff April 8, 2020, 4:12 pm
Arrakis Therapeutics Enters Strategic Collaboration and License Agreement with Roche

by Global Biodefense Staff April 8, 2020, 4:12 pm
BARDA Funds Nanomix to Develop Rapid Mobile COVID-19 Diagnostics

by Global Biodefense Staff April 8, 2020, 2:00 pm

Congratulations. You've reached the end of the internet.

BARDA and Hememics Collaborate to Develop Rapid Diagnostic to Identify SARS-CoV-2

BARDA and Sanofi Prepare for Studies of COVID-19 Vaccine

FDA Accepts for Priority Review for REGN-EB3 to Treat Ebola

Abbott Launches Laboratory-Based Antibody Blood Test with Manufacturing Scaling Targets

BARDA Facilitates Development of Immunotherapies for COVID-19 Patients

BARDA and Vela Diagnostics partner to develop rapid diagnostic test for the COVID-19

Ridgeback Receives UK Clearance to Begin Human Testing of Antiviral for COVID-19

BARDA Supports DiaSorin to Develop a Fully Automated Serology Test to Detect COVID-19 Infections

Lilly Begins Clinical Testing of Therapies for COVID-19

Rapid Lab-Free PCR COVID-19 Test in Development by DnaNudge and Imperial College

DuPont to Produce up to 4.5 Million TYVEK Protective Suits for U.S. Healthcare Workers

HHS Announces Ventilator Contract with Philips under Defense Production Act

Arrakis Therapeutics Enters Strategic Collaboration and License Agreement with Roche

BARDA Funds Nanomix to Develop Rapid Mobile COVID-19 Diagnostics

The Role Nuclear-Related Techniques Play in Fighting Zoonotic Diseases

Relief Funds Being Used to Pay Hospital Shareholders at the Expense of Frontline Health Care Workers

The U.S. Isn’t In a Second Wave of Coronavirus – the First Wave Never Ended

Coronavirus Can Cause Lasting Lung Damage – But the Effects May Ease Over Time

Researchers Identify Multiple Molecules that Shut Down SARS-Cov-2 Polymerase Reaction

Bioxy Decontaminant Agent Tested by DoD Shown Effective Against COVID-19

Air Force COVID-19 Medical Transport: Portable Biocontainment Care Module

CCDC Chemical Biological Center Strives to Become DoD’s Biomanufacturing Leader

Air Force Bioenvironmental Engineers Expand Mission in Aerovac, Close Workspaces

Rapid-Release Gases to Speed Up Cleaning of COVID-19 Ambulances

Chasing the Antidote for Deadly Nerve Agents

Latest Articles